for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Eastman Kodak Company

KODK.N

Latest Trade

7.01USD

Change

0.00(0.00%)

Volume

209,259

Today's Range

7.00

 - 

7.17

52 Week Range

6.29

 - 

14.16

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
7.01
Open
7.10
Volume
209,259
3M AVG Volume
31.67
Today's High
7.17
Today's Low
7.00
52 Week High
14.16
52 Week Low
6.29
Shares Out (MIL)
78.57
Market Cap (MIL)
550.80
Forward P/E
--
Dividend (Yield %)
--

Next Event

Q3 2021 Eastman Kodak Co Earnings Release

Latest Developments

More

Kodak Reports Second-Quarter 2021 Financial Results

Kodak Issues Statement Responding To New York Attorney General

Kodak Reports Qtrly Gaap Net Income Of $6 Million

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Eastman Kodak Company

Eastman Kodak Company is a global technology company that is focused on printing, advancing materials and chemical business. The Company provides hardware, software, consumables and services primarily to customers in commercial print, packaging, publishing, manufacturing and entertainment. The Company’s segments include Traditional Printing, Digital Printing, Advanced Materials and Chemicals and Brand. The Traditional Printing segment is comprised of prepress solutions. The Digital Printing segment is comprised of four lines of business, including the electrophotographic printing solutions business, the prosper business, the versamark business and the kodak software business. The Advanced Materials and Chemicals segment is comprised of four lines of business, including industrial film and chemicals, motion picture, advanced materials and functional printing and kodak services for business. The Brand segment contains the brand licensing business.

Industry

Photography

Contact Info

343 STATE ST

ROCHESTER, NY

14650-0910

United States

+1.585.7244000

https://www.kodak.com/

Executive Leadership

James V. Continenza

Executive Chairman of the Board, Chief Executive Officer

David E. Bullwinkle

Chief Financial Officer, Senior Vice President, President - Eastman Business Park

Terry R. Taber

Chief Technology Officer, Vice President, Senior Vice President of Advanced Materials and Chemicals

John O'Grady

Vice President, Senior Vice President - Print

Randy D. Vandagriff

Senior Vice President - Digital Print, Vice President

Key Stats

Price To Earnings (TTM)
--
Price To Sales (TTM)
0.50
Price To Book (MRQ)
4.23
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
193.08
LT Debt To Equity (MRQ)
191.54
Return on Investment (TTM)
-38.48
Return on Equity (TTM)
-30.14

Latest News

Latest News

Eastman Kodak says New York preparing insider-trading lawsuit

The New York attorney general’s office is preparing an insider-trading lawsuit against Eastman Kodak Co and its top executive, focusing on stock purchases that preceded an ill-fated deal with the Trump administration to finance a pharmaceutical venture during the COVID-19...

Eastman Kodak says New York preparing insider-trading lawsuit

The New York attorney general’s office is preparing an insider-trading lawsuit against Eastman Kodak Co and its top executive, focusing on stock purchases that preceded an ill-fated deal with the Trump administration to finance a pharmaceutical venture during the COVID-19...

Kodak bankruptcy bars claim over toxic chemical exposure - 3rd Circuit

A federal appeals court has upheld the dismissal of a lawsuit against Eastman Kodak Co by a man who claimed he developed an inflammatory spine disease as a result of exposure to a chemical made by the company, finding that the claim was discharged in Kodak's 2013 bankruptcy...

Federal agency finds no wrongdoing in Kodak loan: report

A federal agency found no wrongdoing concerning the stalled U.S. government loan to Eastman Kodak Co, the Wall Street Journal reported on Sunday.

Akin Gump’s Kodak investigation casts doubt on shareholder claims – which Akin Gump is defending

On July 29, just a day after the U.S. International Development Finance Corporation announced a prospective $765 million loan to Kodak to develop pharmaceuticals, the company hired Akin Gump Strauss Hauer & Feld to deal with a flood of demands for documents on the deal...

Kodak surges as review says CEO's option deals broke no laws

Shares of Eastman Kodak Co <KODK.N> surged more than 40% on Wednesday after an independent review cleared its chief executive of insider trading in relation to a $765 million U.S. government loan to produce pharmaceutical ingredients.

Kodak CEO's options grants did not violate internal policies, says law firm

Securities transactions made by Eastman Kodak Co <KODK.N> Chief Executive Officer Jim Continenza around the time the photography equipment maker learned it could receive a $765 million government loan did not violate internal policies, a law firm hired by the company's board...

Kodak raised spending on lobbying government in months before loan awarded

Eastman Kodak Co <KODK.N> increased spending on lobbying the U.S. government in the months before the Trump administration announced a $765 million loan to the photographic equipment maker, public disclosures filed with the Congress show.

Kodak expects sales volumes to rebound after COVID-19 hit

Eastman Kodak Co <KODK.N> said on Tuesday it expects sales volumes and working capital to improve in the current quarter after reporting a 31% decline in quarterly revenue due to the COVID-19 pandemic, sending its shares up 7%.

U.S. loan to Kodak will not proceed unless allegations cleared: White House

The U.S. government will not proceed with a $765 million loan to Eastman Kodak Co <KODK.N> to make drugs at its U.S. factories unless the company is cleared of alleged wrongdoing in circumstances surrounding the announcement of the loan, the White House said on Monday.

Kodak shares plunge after U.S. blocks $765 million loan deal

Shares of Eastman Kodak Co <KODK.N> fell about 40% on Monday and were on track for their worst single-day decline after the U.S. government blocked a $765 million loan to the company, which was going to make drug ingredients for use in possible COVID-19 vaccines, because...

Eastman Kodak's $765 million U.S. loan agreement on hold after recent allegations

Eastman Kodak Co's $765 million loan agreement with the U.S. government to produce pharmaceutical ingredients has been put on hold due to "recent allegations of wrongdoing," the U.S. International Development Finance Corp (DFC) said.

U.S. House Democrats urge SEC to dig into Kodak transactions

The head of the U.S. House Financial Services Committee and other top Democratic lawmakers on Wednesday asked federal regulators to investigate securities transactions made by Eastman Kodak and its executives around the time it learned it could receive a $765 million government...

U.S. House committee urges SEC to dig into Kodak transactions

The U.S. House Financial Services Committee on Wednesday asked federal regulators to investigate securities transactions made by Eastman Kodak and its executives around the time it learned it could receive a $765 million government loan.

U.S. to investigate Kodak's government loan deal, Trump says

The U.S. government will quickly investigate the circumstances surrounding Eastman Kodak Co's announcement of a $765 million government loan to make drugs at its U.S. factories, President Donald Trump said on Tuesday.

Eastman Kodak top executive got Trump deal windfall on an 'understanding'

Eastman Kodak Co on Monday granted its executive chairman options for 1.75 million shares as the result of what a person familiar with the arrangement described as an "understanding" with its board that had previously neither been listed in his employment contract nor made...

Kodak rally builds after surprise U.S. pharma deal

Shares of Eastman Kodak Co <KODK.N> jumped more than 20% in premarket trading on Thursday after ballooning nearly 16 times in value this week, following a $765 million loan from the U.S. government to produce pharmaceutical ingredients.

Kodak CEO's fortune swells $79 million as stocks rally on U.S. government loan

Eastman Kodak Co <KODK.N> CEO Jim Continenza added $79 million to his net worth on Wednesday when his options in the imaging company turned from worthless to lucrative thanks to a U.S. government loan for a pharmaceutical ingredients supply deal that super-charged the value...

Eastman Kodak to get $765 million U.S. loan to make drug ingredients

Eastman Kodak Co <KODK.N> will get a $765 million loan from the U.S. government to produce pharmaceutical ingredients in the country, helping reduce dependency on other countries by strengthening domestic supply chains.

Breakingviews - Drugs are the new bitcoin for stock hype

Eastman Kodak knows how to paint a pretty picture. The company’s stock price at one point had more than tripled on Tuesday after it received a $765 million loan from a U.S. government agency to help produce chemicals used to produce generic drugs. One on the list according...

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up